Epstein Secrets

ous freedom." The Washington Post <https://www.washingtonpost.corn/politics/2020/10/22/amy-coney-barrett-nomination- vote-live-updatesk (10/22, Kim, Firozi, Cassata, I4.2M) reports Barrett "repeatedly declined to offer her legal views on presidential authority and voter intimidation" during her confirma

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

nation, so yes, I think that the supply is probably going to be the most limiting constraint early on." The Washington Post (1/24, Goldstein, Wang, Firozi, Knowles, 10.52M) covers Walensky's remarks and reports that "as officials push to ramp up inoculation efforts to help crush the pandemic, increasi

break from Trump's discursive approach to the pandemic as cases continue to climb nationwide." USA Today (1/24, Rivera, 12.7M) and Politico (1/24, Beasley, 6.73M) also report. US Passes 25M Confirmed Cases; Epidemiologist Pegs Total At More Than 105M. The AP (1/24) says "the new milestone" of 25 milli

y rights, and a wide range of other policy issues including health care access, gun safety and religious freedom." The Washington Post (10/22, Kim, Firozi, Cassata, 14.2M) reports Barrett "repeatedly declined to offer her legal views on presidential authority and voter intimidation" during her confirm

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

y rights, and a wide range of other policy issues including health care access, gun safety and religious freedom." The Washington Post (10/22, Kim, Firozi, Cassata, 14.2M) reports Barrett "repeatedly declined to offer her legal views on presidential authority and voter intimidation" during her confirm

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-